Abstract
The largest published study of renal denervation (RDN), SYMPLICITY HTN–2, demonstrated significant blood pressure (BP) reduction in eligible patients with resistant hypertension. Given the strict inclusion and exclusion criteria of SYMPLICITY HTN–2, we sought to determine its generalizability